ArticleNPJ cardiovascular health2025
Demographic and regional trends of acute myocardial infarction-related mortality among young adults in the US, 1999-2020.
Article in NPJ cardiovascular health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metabolic risk factors associated with premature myocardial infarction in adults ≤ 35 years: a case-control study.BMC cardiovascular disorders · 2026Article
- Beyond Conventional Blood Parameters: Novel Hematologic Indices for Interpretable Artificial Intelligence in Acute Myocardial Infarction.Journal of clinical practice and research · 2025Article
- Myocardical Infarction in Young Adults: Revisiting Risk Factors and Atherothrombotic Pathways.Medicina (Kaunas, Lithuania) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Little is known about how acute myocardial infarction (AMI) mortality has changed over the past two decades in young US adults. We aimed to evaluate the AMI mortality trend among young adults in the US from 1999 to 2020. Data were extracted from the US Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database. Young adults aged 15-44 years with AMI listed as a contributing or underlying cause of death were included. Joinpoint regression was used to estimate the annual percent changes (APCs) and average annual percentage changes (AAPCs) in AMI-related age-adjusted mortality rates (AAMRs). There were 81,272 AMI-related deaths among young adults. The overall AAMR shows a stable trend from 1999 to 2003 (APC 0.2%); a steeper decrease from 2003 to 2009 (APC -4.2%); a steady decrease from 2009 to 2018 (APC -1.8%); and a significant increase from 2018 to 2020 (APC 7.3%); with an AAPC of -1.3% per year (95% CI -2.0% to -0.5%). The AAMR significantly decreased among men (AAPC -1.5%; 95% CI -2.2% to -0.7%), women (AAPC -1.0%; 95% CI -2.4% to -0.4%), non-Hispanic White (AAPC -1.9%; 95% CI -2.6% to -1.1%), and non-Hispanic or African American (AAPC -1.2%; 95% CI -1.8% to -0.6%). Across all geographical regions, the AAMR declined, most significantly in large metropolitan areas (AAPC -1.8%; 95% CI -2.7% to -0.8%). In conclusion, AMI mortality rates among young adults mostly declined from 1999 to 2020, with significant demographic and geographic variation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.